Literature DB >> 29230018

A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells.

Ruihua Ma1, Tiantian Ji1, Huafeng Zhang2, Wenqian Dong2, Xinfeng Chen3, Pingwei Xu1, Degao Chen2, Xiaoyu Liang2, Xiaonan Yin2, Yuying Liu2, Jingwei Ma1, Ke Tang1, Yi Zhang3, Yue'e Peng4, Jinzhi Lu2, Yi Zhang3, Xiaofeng Qin5,6, Xuetao Cao2, Yonghong Wan7, Bo Huang8,9,10.   

Abstract

CD8+ memory T (Tm) cells are fundamental for protective immunity against infections and cancers 1-5 . Metabolic activities are crucial in controlling memory T-cell homeostasis, but mechanisms linking metabolic signals to memory formation and survival remain elusive. Here we show that CD8+ Tm cells markedly upregulate cytosolic phosphoenolpyruvate carboxykinase (Pck1), the hub molecule regulating glycolysis, tricarboxylic acid cycle and gluconeogenesis, to increase glycogenesis via gluconeogenesis. The resultant glycogen is then channelled to glycogenolysis to generate glucose-6-phosphate and the subsequent pentose phosphate pathway (PPP) that generates abundant NADPH, ensuring high levels of reduced glutathione in Tm cells. Abrogation of Pck1-glycogen-PPP decreases GSH/GSSG ratios and increases levels of reactive oxygen species (ROS), leading to impairment of CD8+ Tm formation and maintenance. Importantly, this metabolic regulatory mechanism could be readily translated into more efficient T-cell immunotherapy in mouse tumour models.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29230018     DOI: 10.1038/s41556-017-0002-2

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  35 in total

Review 1.  Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?

Authors:  Gabriele Grasmann; Elisabeth Smolle; Horst Olschewski; Katharina Leithner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 2.  Redox regulation of immunometabolism.

Authors:  Jonathan Muri; Manfred Kopf
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

Review 3.  Metabolic adaptation of lymphocytes in immunity and disease.

Authors:  Nicole M Chapman; Hongbo Chi
Journal:  Immunity       Date:  2022-01-11       Impact factor: 31.745

Review 4.  The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors.

Authors:  Elizabeth G Hunt; Alex M Andrews; Sydney R Larsen; Jessica E Thaxton
Journal:  Front Cell Dev Biol       Date:  2022-04-27

5.  Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells.

Authors:  Ke Tang; Yuandong Yu; Liyan Zhu; Pingwei Xu; Jie Chen; Jingwei Ma; Huafeng Zhang; Haiqing Fang; Weiwei Sun; Li Zhou; Keke Wei; Fei Li; Jiadi Lv; Jing Xie; Yuying Liu; Bo Huang
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

Review 6.  Metabolism as a guiding force for immunity.

Authors:  Jonathan Jung; Hu Zeng; Tiffany Horng
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

Review 7.  Targeting immune cell metabolism in kidney diseases.

Authors:  Paulo José Basso; Vinicius Andrade-Oliveira; Niels Olsen Saraiva Câmara
Journal:  Nat Rev Nephrol       Date:  2021-04-07       Impact factor: 28.314

Review 8.  CD8+ T cell metabolism in infection and cancer.

Authors:  Miguel Reina-Campos; Nicole E Scharping; Ananda W Goldrath
Journal:  Nat Rev Immunol       Date:  2021-05-12       Impact factor: 53.106

9.  Differential transcriptional and functional properties of regulatory T cells in HIV-infected individuals on antiretroviral therapy and long-term non-progressors.

Authors:  Shima Shahbaz; Juan Jovel; Shokrollah Elahi
Journal:  Clin Transl Immunology       Date:  2021-05-26

Review 10.  Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity.

Authors:  Alex M Andrews; Megan D Tennant; Jessica E Thaxton
Journal:  Cancer Immunol Immunother       Date:  2020-10-26       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.